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A b s t r a c t
Background: The relationship between hypertension and oxidative stress remains unexplained. Nevertheless, it is well es-
tablished that reactive oxygen species have an influence on the arterial wall, endothelial function and therefore determine 
blood pressure. 
Aim: The evaluation of selected oxidative stress markers in hypertensive patients and an assessment of the relationship be-
tween oxidative stress markers and the arterial structure and function. We also aimed to investigate whether the influence of 
oxidative stress on remodelling of arteries, their structural and functional changes is independent of hypertension or is related 
to hypertension. 
Methods: Altogether 217 subjects (114 female, 103 male) were enrolled from hypertensive families. The mean age was 
45.5 ± 16 years, and the group included 155 hypertensives. In every subject, the pulse wave velocity and intima–media 
thickness (IMT) in carotid arteries were measured as well as selected oxidative stress markers such as asymmetric dimethyl-
arginin (ADMA), symmetric dimethylarginin (SDMA), advanced oxidation protein products (AOPP) and oxidised low density 
lipoproteins (ox-LDL).
Results: The results of multivariate analysis show that in hypertensive patients: the ADMA level increased with increasing 
peripheral pulse pressure (b = 0.003; p < 0.001), and AOPP was related to higher carotid IMT (b = 0.91; p = 0.036). 
In normotensive subjects, the following associations were found: between ADMA and central pulse pressure (b = 0.006; 
p = 0.008), between SDMA and the peripheral augmentation index (b = –0.03; p = 0.014), between AOPP and the pe-
ripheral augmentation index (b = 0.011; p = 0.04), and between ox-LDL/LDL ratio and the peripheral augmentation index 
(b = –0.025; p = 0.004). The SDMA/ADMA ratio was associated with estimated glomerular filtration rate in both groups 
(b = –0.0061; p < 0.0001 and b = –0.005; p < 0.017, respectively). In hypertensives, we observed a relation with peripheral 
pulse pressure (b = –0.0067; p = 0.0143). Moreover, in normotensives there was an association between the SDMA/ADMA 
ratio and uric acid (b = 1.3629; p = 0.046). 
Conclusions: We found that the influence of oxidative stress on the structure and function of large arteries was independent 
of hypertension. Therefore oxidative stress may play a significant role in the development of arterial stiffness. Higher oxidative 
stress is associated with more advanced arterial remodelling in hypertension.
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INTRODUCTION
Hypertension (HT) is one of the commonest cardiovascular 
risk factors and the leading cause (32%) of death in Poland [1]. 
Severe complications of HT and its high prevalence have 
made primary prevention and early diagnosis a priority for 
healthcare services worldwide. 
www.kardiologiapolska.pl
Łukasz Klima et al.
918
Recent studies have suggested that oxidative stress 
plays some role in the functioning and structure of the arter-
ies. Elevated reactive oxygen species (ROS) leads to increased 
resistance of the arteries due to the reduction of nitric oxide 
(NO) availability, the peroxidation of membrane lipids, the 
impairment of relaxation, and the stimulated proliferation 
of smooth muscle cells. Elevated blood pressure (BP), on 
the other hand, caused by angiotensin II, xanthine oxidase, 
mechanical stress increases ROS activation and leads to the 
impairment of the endothelial function. 
The main factor influencing endothelial function is NO. Its 
production depends on the availability of a cofactor for NO syn-
thase such as tetrahydrobiopterin and endogenous competitive 
inhibitors of NOS such as asymmetric dimethylarginin (ADMA) 
or N-monomethylarginin (L-NMMA). The correlation between 
ADMA and BP has been proven [2]. Weber et al. [3] discovered 
that the ADMA level in serum is related to the central augmenta-
tion index. They evaluated the quantitative relationship between 
plasma levels of ADMA and arterial wave reflection assessed 
by pulse wave analysis technique as well as aortic pulse wave 
velocity (PWV) measured invasively during coronary angiography.
PWV and the distance of reflection points to the heart are 
the main determinants of the peripheral and central augmen-
tation indices. Wave reflection occurs at sites of changes of 
arterial impedence along the arterial tree, such as branching 
points or atherosclerotic plaques. The peripheral and central 
augmentation indices increase with age and mean arterial 
pressure and are inversely related to heart rate and body 
height. Augmentation index predicts clinical events indepen-
dently of peripheral pressures. As diagnostic thresholds, the 
following values have been proposed for middle-aged men 
(i.e. 40 years and above): 90% for the peripheral augmenta-
tion index, and 30% for the central augmentation index [4].
Zoccali et al. [5] found that ADMA was an independent 
predictor of carotid intima–media thickness (IMT) thickening. 
In the case of another oxidative stress marker (oxidised low 
density lipoproteins — ox-LDL), it also affects BP because it 
interacts with the RAA system [6]. Advanced oxidation protein 
products (AOPP) are considered a risk factor of atherosclerosis 
and coronary artery disease (CAD) [7]. Lower concentrations 
of symmetric dimethylarginin (SDMA) that are commonly 
found in serum, do not inhibit NOS, therefore it was consid-
ered an insignificant substance until Kiechl et al. [8] revealed 
that ADMA is not a better marker than SDMA for cardiovas-
cular risk. Family predisposition to the development of HT 
may be manifested by exacerbated oxidative stress, and this 
leads to changes in the arterial wall even before HT develops. 
The relationship between oxidative stress and HT remains 
still unexplained. It is considered to be a vicious circle of 
reactive oxygen species — that are both cause and result of 
HT. Thus the aim of this study was to assess selected oxida-
tive stress markers in HT and normotensive subjects, and to 
analyse their relationship with the parameters of the arterial 
structure and function while adjusting for confounders. We 
also aimed to investigate whether the influence of oxidative 
stress on remodelling of arteries, their structural and functional 
changes is independent of HT or related to HT. 
METHODS
The study was conducted within the framework of The 
InGenious HyperCare Network of Excellence [9]. Subjects 
were recruited from the Outpatient Hypertensive Clinic at the 
1st Department of Cardiology and Hypertension, Jagiellonian 
University Medical College. Then their family members were 
enrolled — at least three people from two generations. We re-
cruited 50 families, with altogether 217 subjects (114 women, 
103 men). All participants signed a form which gave their in-
formed consent. The protocol of the study was approved by the 
Bioethics Committee at the Jagiellonian University in Krakow.
Office BP measurement was performed according to the 
ESH guidelines [10]. Peripheral pulse pressure was defined as 
the difference between the mean systolic (SBP) and diastolic 
(DBP) office blood pressure. 
In every subject, 24-h ambulatory blood pressure monitoring 
(ABPM) was performed with SpaceLabs 90207 (Redmont, WA, 
USA) with measurements every 15 min during the day (between 
6 a.m. and 10 p.m.) and every 20 min at night. We adopted the cri-
teria for incorrect measurements introduced by Staessen et al. [11].
Aortic PWV was evaluated with a Sphygmocor® device. 
The pulse wave on the carotid and femoral artery was recorded, 
then on the carotid and radial artery. The distance between the 
recording points and the sternal notch was measured and PWV 
was calculated as a fraction of the distance and foot–to–foot time. 
For pulse wave analysis after 5 min rest in the supine posi-
tion, the pulse wave on the radial artery was recorded with 
a microtip pressure transducer (Model SPT-301, Millar Instru-
ments, Houston, TX, USA) and with Sphygmocor® software 
(ver. 6.31 AtCor Medical Pty., Ltd., Australia). After recording 
the radial pulse wave, the central BP wave was obtained and 
the peripheral and central augmentation indices (AIx p [%] and 
AIx c [%], respectively) were calculated. Peripheral AIx was 
defined as the quotient of the second (P2) and first (P1) peak 
of SBP. The central AIx was defined as the difference between 
P2 and P1 divided by the central pulse pressure (PP c).
For the evaluation of structural changes in the arterial 
wall, ultrasonography of the carotid arteries was performed 
using a two-dimensional projection along a longitudinal axis 
with 10 MHz probe and a Vivid 7 PRO GE device. The IMT 
was measured 2 cm proximally from the bulb of the common 
carotid artery and its bifurcation on far wall with semiauto-
matic method provided with GE software.
Laboratory tests
We collected fasting blood samples for measurements of 
the following parameters: glucose, cholesterol, low den-
sity lipoprotein cholesterol (LDL-C), high density lipoprotein 
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cholesterol (HDL-C), triglycerides, creatinine, and uric acid. 
Repeated morning urine samples were collected to measure 
albumin and creatinine in urine. Selected oxidative stress 
markers were assessed: ADMA, SDMA and ox-LDL with ELISA 
tests and AOPP with spectroscopic analysis.
Statistical analysis
All statistical analyses were performed with STATISTICA 9.1 soft-
ware and R 2.13. Continuous variables were presented as 
means with standard deviation. Categorical variables were pre-
sented as numbers and percentages. The Shapiro-Wilk test was 
used to assess the normality of continuous variables. The AOPP 
and ox-LDL/LDL ratio were logarithmically (log10) transformed. 
To examine differences between two independent groups, 
the Student’s t-test was used. The Fischer exact or c2 tests 
were used to compare categorical variables. The unadjusted 
associations between continuous variables were examined by 
Pearson’s or Spearman’s correlation coefficient as appropriate. 
The association between variables adjusted for confounders 
was examined by stepwise multivariate regression. Two sided 
p-values < 0.05 were considered statistically significant.
RESULTS
Group characteristics
In our group of 50 families, the most prevalent family struc-
ture consisted of a subject and his/her parents and one sib-
ling (20 families). The second most common structure was 
a subject, one parent and two siblings (six families). The study 
population characteristics are summarised in Table 1. Normo-
tensives (n = 62) compared to hypertensives (n = 155) were 
younger, had lower body mass index (BMI) and waist to hip 
ratio (WHR), lower glucose and triglyceride level, and higher 
HDL-C. Hypertensives had a lower estimated glomerular 
filtration rate (eGFR). Night-time DBP decrease was signifi-
cantly more pronounced in normotensives. 
Selected arterial parameters which differ between the 
groups of hypertensive and normotensive subjects are pre-
sented in Table 2. 
The levels of oxidative stress markers did not differ between 
men and women with the exception of AOPPs which were 
higher in men (3.69 ± 0.96 vs. 3.4 ± 0.9 µmol/L; p = 0.027).
In the hypertensive group, angiotensin converting enzyme 
(ACE) inhibitors were administered in 71 patients and angioten-
sin receptor blockers (ARB) in 25. Thus, 62% of hypertensive 
subjects were treated with drugs with a strong influence on 
oxidative stress [12]. Moreover beta-blockers were adminis-
tered in 61, calcium channel blockers in 46 and diuretics in 
74 patients, whereas statins were administered in 28 patients.
Multivariate analysis
We did not observe any significant differences in ADMA, 
SDMA, AOPP or ox-LDL between normotensives and hyper-
Table 1. Characteristics of the study population 
Hypertensives
N = 155 (71.4%)
Men/women: 74/81
Normotensives
N = 62 (28.6%)
Men/women: 29/33
P 
Age [years] 48.95 ± 15.19 36.98 ± 14.73 < 0.001
Height [cm] 168.80 ± 9.28 169.23 ± 9.04 0.7563
Weight [kg] 81.29 ± 14.69 70.28 ± 14.43 < 0.001
Body mass index [kg/m2] 28.47 ± 4.26 24.43 ± 3.99 < 0.001
Waist to hip ratio 0.89 ± 0.08 0.85 ± 0.09 < 0.001
SBP [mm Hg] 144.15 ± 22.11 127.64 ± 11.89 < 0.001
DBP [mm Hg] 85.87 ± 11.69 78.86 ± 8.49 < 0.001
HR [bpm] 72.82 ± 11.62 74.31 ± 9.30 0.3235
Glucose [mmol/L] 5.42 ± 1.30 4.94 ± 0.66 < 0.001
LDL-C [mmol/l] 2.99 ± 0.90 2.82 ± 0.97 0.97
Cholesterol [mmol/L] 5.17 ± 1.05 4.87 ± 1.19 0.0867
HDL-C [mmol/L] 1.43 ± 0.37 1.61 ± 0.39 0.0021
Triglycerides [mmol/L] 1.70 ± 0.93 1.12 ± 0.60 < 0.001
eGFR [mL/min/1.73 m2] 100.41 ± 21.82 116.07 ± 26.20 < 0.001
24 h DBP [mm Hg] 77.10 ± 9.05 72.92 ± 6.71 < 0.001
24 h SBP [mm Hg] 126.77 ± 11.38 119.85 ± 8.43 < 0.001
24 h HR [bpm] 71.17 ± 9.69 76.11 ± 8.24 < 0.001
Data is shown as mean ± SD; 24h DBP, SBP, HR — 24h ABPM parameters respectively systolic, diastolic blood pressure and mean heart rate;  
eGFR — estimated glomerular filtration rate; HDL — high density lipoprotein cholesterol; LDL — low density lipoprotein cholesterol
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tensives after adjusting for potential confounders, i.e. age, 
BMI, WHR, uric acid, eGFR, sex, smoking, PWV, IMT, AIx, 
office BP in standard measurements and ABPM. The details 
are presented in Table 3. Correlations are related to office BP.
Using multivariate analysis, we found that in hypertensive 
patients (Table 4), ADMA was independently related to eGFR 
and the peripheral pulse pressure (b = 0.003; p < 0.001). 
SDMA showed a positive correlation to uric acid and a nega-
tive correlation to eGFR. AOPPs were significantly correlated 
to IMT (b = 0.91; p = 0.036) and uric acid. Ox-LDL/LDL 
ratio had a negative relation to DBP. 
In normotensives, an association between ADMA and 
eGFR and the central pulse pressure (b = 0.006; p = 0.008) 
was observed. SDMA was related to the peripheral AIx 
Table 2. Arterial stiffness parameters
Hypertensives
N = 155 (71.4%)
Normotensives
N = 62 (28.6%)
P
PWV (c-r) [cm/s] 841.51 ± 139.58 785.48 ± 119.18 0.004
PWV (c-f) [cm/s] 881.19 ± 217.89 745.13 ± 158.27 < 0.001
IMT [mm] 0.63 ± 0.16 0.53 ± 0.13 < 0.001
AIx p [%] 79.11 ± 24.22 60.23 ± 20.54 < 0.001
AIx c [%] 23.38 ± 16.32 10.93 ± 16.23 < 0.001
PP p [mm Hg] 57.58 ± 13.37 52.34 ± 11.44 0.0046
PP c [mm Hg] 44.45 ± 12.64 35.36 ± 9.63 < 0.001
Data is shown as mean ± SD; PWC c-r — carotid radial pulse wave velocity; PWV c-f — carotid femoral pulse wave velocity; IMT — intima-media thick-
ness; AIx p — peripheral augmentation index; AIx c — central augmentation index; PP p — peripheral pulse pressure; PP c — central pulse pressure
Table 3. Oxidative stress markers
Hypertensives
N = 155 (71.4%)
Normotensives
N = 62 (28.6%)
P
ADMA [mmol/L] 0.56 ± 0.16 0.58 ± 0.17 0.4989
SDMA [mmol/L] 0.74 ± 0.20 0.71 ± 0.17 0.4287
Log (AOPP) [mmol/L] 3.54 ± 0.96 3.54 ± 0.90 0.9983
Log (ox-LDL/LDL) [ng/mL/mmol/L] 4.18 ± 1.25 4.19 ± 1.25 0.9425
SDMA/ADMA 1.40 ± 0.53 1.31 ± 0.45 0.223
Data is shown as mean ± SD; ADMA — asymmetric dimethylarginin; SDMA — symmetric dimethylarginin; ox-LDL — oxidised low density lipopro-
teins; AOPP — advanced oxidation protein products
Table 4. Determinants of oxidative stress markers in hypertensive patients: multivariate analysis
ADMA SDMA Log (AOPP) Log (ox-LDL/LDL) SDMA/ADMA
b p b p b p b p b p
Intercept 0.2818 0.0002 1.0000 0.0000 2.4406 0.0000 6.2664 0.0000 2.3534 < 0.001
Hypertension –0.0199 0.4516 –0.0047 0.8841 –0.2059 0.1740 0.1604 0.4272 0.0542 0.5147
BMI NS NS -0.0064 0.0489 NS NS NS NS NS NS
Uric acid NS NS 0.4495 0.0089 2.6258 0.0018 NS NS NS NS
eGFR 0.0012 0.0171 –0.0023 0.0001 NS NS NS NS -0.006 < 0.001
Ex-smoker NS NS NS NS –0.4052 0.0104 NS NS NS NS
IMT NS NS NS NS 0.9108 0.0368 NS NS NS NS
PP p 0.0031 0.0005 NS NS NS NS NS NS –0.0067 0.0143
DBP NS NS NS NS NS NS –0.026 0.001 NS NS
Additional variables included in multivariate analysis: age, waist to hip ratio and gender were non-significant; ADMA — asymmetric dimethyl-
arginin; SDMA — symmetric dimethylarginin; ox-LDL — oxidised low density lipoproteins; AOPP — advanced oxidation protein products;  
IMT — intima-media thickness; b — regression coefficient; PP p — peripheral pulse pressure; PP c — central pulse pressure; BMI — body mass 
index; eGFR — estimated glomerular filtration rate; DBP — diastolic blood pressure; NS — non-significant
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(b = –0.03; p = 0.014). For AOPP we observed a relationship 
with peripheral AIx (b = 0.011; p = 0.04) and sex. For the 
ox-LDL/LDL ratio, there were significant relations with BMI, 
central pulse pressure (b = 0.053; p = 0.008) and peripheral 
AIx (b = –0.025; p = 0.004) (Table 5). Moreover, there was 
a significant relationship between the SDMA/ADMA ratio and 
uric acid and eGFR in both hypertensives and normotensives 
(b = –0.0061; p < 0.0001 and b = –0.005; p < 0.017, 
respectively). Additionally, in hypertensives there was 
a relationship with peripheral pulse pressure (b = –0.0067; 
p = 0.0143), and in normotensives SDMA/ADMA ratio was 
associated with uric acid (b = 1.3629; p = 0.046). 
DISCUSSION
Methylated arginines, ox-LDL or advanced oxidation protein 
products represent the set of markers recently widely investi-
gated as potential measures of oxidative stress [13].
In our study we did not observe differences in ADMA, 
SDMA, ox-LDL or AOPP plasma levels between hypertensive 
and normotensive participants. Studies on oxidative stress 
markers in HT have provided varying results. Schlaich et al. 
[14] had similar results to ours. On the other hand, Surdacki 
et al. [15] observed an elevated ADMA concentration in newly 
diagnosed, not yet treated, hypertension. Perticone et al. [16] 
showed that the ADMA level is higher in hypertensives com-
pared to a normotensive control group. Most studies by other 
groups have observed ADMA concentrations of approximately 
2.6 mmol/L or more in hypertensives, such as would be found 
in end-stage renal disease or heart failure [17]. In our study, 
the mean ADMA concentration was 0.58 mmol/L in normo-
tensives, and 0.56 µmol/L in hypertensives, much lower than 
in other studies. Schlaich et al. [14] also had lower concentra-
tions of ADMA and SDMA in serum (for ADMA 1.11 mmol/L in 
normotensives without a family history of HT, 0.87 mmol/L in 
normotensives with a family history of HT and 1.61 mmol/L; for 
SDMA 0.37 mmol/L in normotensives without a family history 
of HT, 0.55 mmol/L in normotensives with a family history of 
HT and 0.59 mmol/L in hypertensives). Our findings may be 
the result of the treatment of hypertensive patients with RAAS 
antagonists such as ACE inhibitors or ARB as these drugs have 
a proven effect on oxidative stress reduction.
Mizayaki et al. [2] found a positive correlation between 
the concentration of ADMA and mean BP in 118 subjects 
(40 with HT) without concomitant cardiovascular diseas-
es. Moreover, Weber et al. [3] showed a negative correlation 
of ADMA with DBP on the brachial artery and in the aorta. In 
multivariate analysis, we did not however observe a relation-
ship between ADMA and BP. In the group of normotensives, 
an independent relationship between ADMA and the central 
BP was observed. On the other hand, in multivariate analysis, 
as in the study by Weber et al. [3], we observed a negative 
correlation between DBP and the oxidative stress marker.
A recently published meta-analysis [18] showed that 
carotid–femoral PWV is an independent risk factor for death 
and cardiovascular death. Weber et al. [3] observed that 
ADMA levels in serum are associated with arterial stiffness 
estimated with central augmentation index (c AIx) as well as 
carotid–femoral PVW. The authors showed that in the whole 
cohort ADMA correlates with AIx and augmentation pressure 
[3], and that this correlation was significant for adults below 
as well as above the age of 60. In our study, in multivariate 
analysis, the peripheral AIx correlated with AOPP in normo-
tensives and an association between ADMA and PP p was 
present. In the Delles et al. study [19] comparing arterial 
stiffness in CAD patients to a control group, there was no 
difference in AIx (%) between the two groups. There was 
a difference in terms of PWV and aortic compliance. Ox-LDLs 
were lower in the study group but the ratio ox-LDL/LDL was 
higher. In our study there was no difference between groups 
for ox-LDL/LDL but Delles et al. [19] investigated patients 
with CAD. Our patients had HT without CAD. Additionally, 
we did not observe a correlation between the oxidative stress 
markers and the superoxide anion production in the vascular 
wall [19]. However, in the study by Delles et al. [19], patients 
with CAD were treated with ACE inhibitors, statins. Delles et 
al. [19] showed a correlation between O2 production in the 
vascular wall and aortic compliance which persisted even 
after adjusting for classical risk factors. In multivariate analysis, 
we observed a positive correlation between AIx p and AOPP 
and a negative correlation for SDMA and ox-LDL/LDL ratio 
in normotensives. There was a positive correlation between 
ADMA and central pulse pressure in this group. The relation-
Table 5. Family hypertension burden and oxidative stress
1 relative ≥ 2 relatives P
ADMA [mmol/L] 0.57 ± 0.16 0.58 ± 0.17 0.7362
SDMA [mmol/L] 0.71 ± 0.17 0.72 ± 0.18 0.8270
Log (AOPP) [mmol/L] 3.33 ± 1.07 3.62 ± 0.84 0.3748
Log (ox-LDL/LDL) [ng/mL/mmol/L] 3.88 ± 1.38 4.31 ± 1.21 0.3024
SDMA/ADMA 1.32 ± 046 1.32 ± 0.45 0.9862
Data is shown as mean ± SD; abbreviations as in Table 3
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ship between ox-LDL/LDL and arterial stiffness was shown in 
a group of young, middle-aged subjects and in the elderly 
(n = 2295) [20]. Brinkley et al. [20] observed that higher 
ox-LDLs are related to higher LDL and triglyceride, and that 
smoking, age, and drugs were not different in terciles of 
ox-LDL. The same investigators compared PWV in the same 
age category with high and low ox-LDL values and described 
higher arterial stiffness in the group with higher ox-LDL values. 
Our study did not confirm the hypothesis that ox-LDL 
are markers of oxidative stress and are independent of other 
cardiovascular risk factors influencing arterial stiffness. 
Zoccali et al. [5] observed that elevated ADMA were in-
dependent predictors of carotid IMT. Furuki et al. [21] showed 
that ADMA correlates with carotid IMT independently of BP, 
age and sex. In our observations in multivariate analysis the 
relationship between AOPP and IMT stayed significant in 
hypertensive patients. ADMA was also shown to be connected 
with IMT in healthy subjects, which suggests it is an important 
marker of atherosclerosis [2]. 
We suspected that antihypertensive pharmacotherapy 
may be one of the reasons why we did not observe any dif-
ferences in oxidative stress markers between normotensives 
and hypertensives. Most of our patients were on drugs which 
inhibited the RAA system. These drugs have a proven effect 
on oxidative stress markers [22–24]. Additionally, several 
individuals were treated with statins or beta-blockers which 
also interfere with oxidative stress [25].
The novel findings of our study may throw some light on 
understanding the relation between organ damage and oxida-
tive stress in HT and on understanding the role of methylated 
arginines or advanced oxidation protein products which may 
be significant in the search for new antihypertensive drugs. 
CONCLUSIONS
We found that the influence of oxidative stress on the structure 
and function of large arteries is independent of HT. Therefore, 
oxidative stress may play a significant role in the development 
of arterial stiffness. Higher oxidative stress is associated with 
more advanced arterial remodelling in HT. 
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S t r e s z c z e n i e
Wstęp: Zależność między nadciśnieniem tętniczym a stresem oksydacyjnym nadal jest przedmiotem badań. Udowodniono, 
że reaktywne formy tlenu wpływają na ścianę tętnic oraz funkcję śródbłonka i w ten sposób mogą determinować wartość 
ciśnienia tętniczego. 
Cel: Celem badania była ocena wybranych markerów stresu oksydacyjnego u pacjentów z nadciśnieniem tętniczym oraz 
ocena zależności między tymi markerami a wskaźnikami struktury i funkcji naczyń tętniczych.
Metody: Do badania włączono 217 osób (114 kobiet, 103 mężczyzn), pochodzących z rodzin, w których występowało nad-
ciśnienie tętnicze. Średni wiek badanych wynosił 45,5 ± 16 lat, u 155 osób rozpoznano nadciśnienie tętnicze. U każdego 
z uczestników wykonano pomiar prędkości fali tętna oraz ultrasonograficzną ocenę grubości kompleksu błony środkowej 
i wewnętrznej (IMT) tętnic szyjnych wspólnych. Jako wskaźniki stresu oksydacyjnego oznaczono asymetryczną dimetyloargininę 
(ADMA), symetryczną dimetyloargininę (SDMA), produkty zaawansowanej oksydacji białek (AOPP) i utlenowane lipoproteiny 
o niskiej gęstości (ox-LDL). 
Wyniki: W analizie wieloczynnikowej wykazano, że u pacjentów z nadciśnieniem stężenie ADMA zwiększało się wraz ze 
wzrostem obwodowego ciśnienia tętna (b = 0,003; p < 0,001), a AOPP wiązało się z wyższym wskaźnikiem IMT w tętni-
cach szyjnych (b = 0,91; p = 0,036). Wśród osób z prawidłowymi wartościami ciśnienia zaobserwowano zależności między 
ADMA i centralnym ciśnieniem tętna (b = 0,006; p = 0,008), SDMA i obwodowym wskaźnikiem wzmocnienia (b = –0,03; 
p = 0,014), AOPP i obwodowym wskaźnikiem wzmocnienia (b = 0,011; p = 0,04), wskaźnikiem ox-LDL/LDL a obwodowym 
wskaźnikiem wzmocnienia (b = –0,025; p = 0,004). Wskaźnik SDMA/ADMA wiązał się z estymowaną filtracją kłębuszkową 
w obydwu grupach (odpowiednio: b = –0,0061; p < 0,0001 i b = –0,005; p < 0,017). U pacjentów z nadciśnieniem tętni-
czym zaobserwowano związek powyższego parametru z obwodowym ciśnienia tętna (b = –0,0067; p = 0,0143). Ponadto 
u osób z prawidłowymi wartościami ciśnienia zanotowano zależność między wskaźnikiem SDMA/ADMA a stężeniem kwasu 
moczowego (b = 1,3629; p = 0,046).
Wnioski: Stres oksydacyjny wpływa na strukturę i funkcję naczyń tętniczych niezależnie od nadciśnienia tętniczego i może 
odgrywać istotną rolę w rozwoju sztywności tętnic. 
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